TLSI – trisalus life sciences, inc. (US:NASDAQ)
Stock Stats
News
TriSalus Reports Q1 2024 Financial Results and Business Update
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Jonestrading. They set a "buy" rating and a $16.00 price target on the stock.
TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.